Skip to main content Skip to section navigation Skip to footer
chevron_leftBack to Evommune.com

Check Out the EADV Webinar of Full Phase 2 Data for Oral MRGPRX2 Inhibitor EVO756 in Chronic Inducible Urticaria.

Click Here
Evommune Corporate Home
  • About Us
    • Overview
    • Leadership
    • Collaborating
    • Contact
  • Our Science
    • Approach
    • Disease Focus
    • Publications & Posters
  • Our Pipeline
    • Development Pipeline
    • MRGPRX2 Antagonist
    • IL-18bp Fusion Protein
    • Clinical Trials
  • Join Us
    • Our Culture
    • Job Openings
  • Investors & Media
    • Overview
    • Company Info
      • Management Team
      • Presentations
      • Contacts
      • FAQ
    • News & Events
      • Press Releases
      • IR Calendar
      • Email Alerts
    • Stock Data
      • Quote & Chart
      • Historical Data
      • Analyst Coverage
    • Financial & Filings
      • Financial Results
      • SEC Filings
    • Corporate Governance
      • Board of Directors
      • Board Committees
      • Governance Documents
Select Page
Evommune, Inc. IR Overview
  • Overview
  • Company Info
    • Management Team
    • Presentations
    • Contacts
    • FAQ
  • News & Events
    • Press Releases
    • IR Calendar
    • Email Alerts
  • Stock Data
    • Quote & Chart
    • Historical Data
    • Analyst Coverage
  • Financial & Filings
    • Financial Results
    • SEC Filings
  • Corporate Governance
    • Board of Directors
    • Board Committees
    • Governance Documents
  • chevron_leftBack to Evommune.com

IR Calendar

Overview

Overview

  • Overview
  • Company Info
    • Management Team
    • Presentations
    • Contacts
    • FAQ
  • News & Events
    • Press Releases
    • IR Calendar
    • Email Alerts
  • Stock Data
    • Quote & Chart
    • Historical Data
    • Analyst Coverage
  • Financial & Filings
    • Financial Results
    • SEC Filings
  • Corporate Governance
    • Board of Directors
    • Board Committees
    • Governance Documents

  • News & Events

  • Press Releases
  • IR Calendar
  • Email Alerts

KOL Webinar Highlighting Role of MRGPRX2 in Migraine

Apr 13, 2026 2:00 pm EDT
WebcastAudio
PresentationPDF
  • location_cityCompany Profile
  • contact_pageContacts
  • rss_feedRSS News Feed
  • account_treeSitemap
  • accessibilityAccessibility Statement

About Us

  • Overview
  • Leadership
  • Collaborating
  • Contact

Our Science

  • Approach
  • Disease Focus
  • Publications & Posters

Our Pipeline

  • Development Pipeline
  • MRGPRX2 Antagonist
  • IL-18bp Fusion Protein
  • Clinical Trials

Join Us

  • Our Culture
  • Job Openings

Investors & Media

  • Overview
  • Company Info
  • News & Events
  • Stock Data
  • Financial & Filings
  • Corporate Governance
© 2026 Evommune, Inc.
  • Privacy Policy
  • Terms of Use
in
logo

Website by 22 Fillmore